Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avastin and Chemotherapy in Metastatic Colorectal Cancer
NCT00449163Phase 2Terminated
- Sponsor
- University of Miami
- Start
- Mar 2006
- Primary completion
- Mar 2010
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of bevacizumab in metastatic colorectal cancer (mCRC), sponsored by University of Miami. Primary endpoint: Overall Survival at 2 years. Started Mar 2006; status: terminated.
02
Drugs
bevacizumab
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT00449163.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00449163.